Skip to content
Medical Health Aged Care, Women

Study underlines the importance of supporting primary care clinicians to deliver early medical abortion and long acting reversible contraception

Monash University 2 mins read

The impetus for additional support and training for clinicians wanting to deliver important sexual and reproductive services has received a boost with the release of Monash University-led research.

Published in BMJ – Sexual and Reproductive Health, the AusCAPPS study found that GPs, nurses and pharmacists seek peer support and online resources to deliver long-acting reversible contraception (LARC) and early medical abortion (EMA) in Australian primary care.

Experienced and emerging providers of LARC and EMA sought support regarding clinical issues online from AusCAPPS, which is the Australian Contraception and Abortion Primary Care Practitioner Support Network, an evidence-based virtual community of practice launched by the SPHERE Centre of Research Excellence in July 2021.

This research confirmed the importance of the Network.

AusCAPPS was recently funded for a further 2.5 years as part of the Federal Government’s commitment to supporting women’s health in primary care, to support GPs, nurses and pharmacists who want to provide LARC and EMA in primary care.

Uptake of LARC is lower in Australia (11 per cent) compared with other high-income countries (>30 per cent). Additionally, with only about 11 per cent of GPs providing EMA, women's access to these services are greatly dependent on where they live,” explained first author GP and SPHERE Centre of Excellence research fellow, Dr Sonia Srinivasan.

“Our study found that primary care clinicians are looking for practical and professional support to provide LARC and EMA. GPs want to boost their clinical knowledge with input from peers and experts, nurses are looking for ways to overcome the challenges faced delivering these services in clinical practice and pharmacists seek clarity around the regulations that guide the dispensing of drugs.”

The paper explained that barriers to primary care provision of LARC and EMA include a lack of provider education and training opportunities, inadequate support and stigma. LARC and EMA services are concentrated in metropolitan areas, and high out-of-pocket costs create additional barriers for young, rural and remote Australian women in particular.

The AusCAPPS Network, which has more than 2600 members (60 per cent are GPs, 14 per cent nurses, and 22 per cent pharmacists), is used extensively by participants and welcomes new members. 

The study, which surveyed 2021-2023 AusCAPPS members, found that health professional peer support, point-of-care patient guides and educational webinars and podcasts were crucial online tools that supported GPs, nurses and pharmacists to deliver local LARC and EMA services.

In order to increase women’s access to these essential reproductive health services, we need more GPs, nurses and pharmacists involved in the provision of LARC and EMA,” Dr Srinivasan said. Our research demonstrates what GPs, nurses and pharmacists actually need in practice to support this objective.”

This research, undertaken with the support of the Royal Australian College of General Practitioners (RACGP) Foundation, builds on a range of research and initiatives by SPHERE and AusCAPPS to build the capacity of primary care to deliver Early Medical Abortion and Long Acting Reversible Contraception, including in rural and remote communities.

Read the full paper in BMJ Sexual and Reproductive Health:
What do Australian primary care clinicians need to provide long-acting reversible contraception and early medical abortion? A content analysis of a virtual community of practice 

DOI:  10.1136/bmjsrh-2024-202330

For media enquiries please contact:

Monash University

Cheryl Critchley – Media and Communications Manager (medical)
E:
[email protected]

T: +61 (0) 477 571 442

 

For more Monash media stories, visit our news and events site 


For general media enquiries please contact:
Monash Media
E: 
[email protected]
T: +61 (0) 3 9903 4840

 

***ENDS***

 

More from this category

  • Medical Health Aged Care, Research Development
  • 11/07/2025
  • 16:28
The Florey

Harnessing mRNA to prevent and slow Alzheimer’s disease

mRNA Victoria funds 2Floreyprojects to prevent and treat Alzheimer’s disease Key points mRNA Victoria has funded 2 Alzheimer’s disease research projects that could position Victoria as a leader in the development of mRNA-based therapies. Dr Abdel Belaidi will develop an mRNA-based system that crosses the blood-brain barrier and aims to slow or even halt disease progression. Dr Rebecca Nisbet will develop an mRNA vaccine that aims to prevent Alzheimer’s disease from developing. Florey researchers working at the cutting edge of dementia research have received funding from mRNA Victoria to develop treatments and a vaccine for Alzheimer’s disease. Since mRNA vaccines…

  • Medical Health Aged Care
  • 11/07/2025
  • 07:05
Royal Australian College of GPs

GPs urge Tasmanian families to get vaccinated against whooping cough and call for free shots to reduce barriers

The Royal Australian College of GPs (RACGP) is urging Tasmanian families to get vaccinated against pertussis, or ‘whooping cough’ and called on all parties and candidates running in the state election to commit to making the vaccination free for all patients. From 1 January 2024 to April 2025, 1238 whooping cough cases were notified in Tasmania, including 10 infants aged under six months. Most hospitalisations and deaths occur in this group, who are not old enough to have received all vaccine doses. More than 21,000 infections were recorded nationwide last year, compared to just 2450 in 2023, and the National…

  • Contains:
  • General News, Medical Health Aged Care
  • 11/07/2025
  • 07:00
La Trobe University

La Trobe researchers awarded $4.5 million in ARC Future Fellowships

LaTrobe University researchers have secured almost $4.5 million in Federal Government funding to further studies into areas such as immune cell development, Australian history and agriculture. Four researchers received an Australian Research Council (ARC) Future Fellowship 2025. The prestigious Future Fellowships support high quality research in areas of national and international benefit, including in national research priorities. Dr Lisa Mielke, from the School of Cancer Medicine, the La Trobe Institute of Molecular Science (LIMS) and the Olivia Newton-John Cancer Research Institute (ONJCRI), received $1.13 million to identify new molecules for future drug and vaccine development to improve gut health in…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.